Srita Chakka

Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis

Sarah Ahmed, Srita Chakka, Josef Symon S. Concha et al. · British Journal of Dermatology · 2019 · 37 citations · Full text

Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus

Srita Chakka, Rebecca L. Krain, Sarah Ahmed et al. · Journal of the American Academy of Dermatology · 2020 · 28 citations · Full text

Quality Of Life, Disease Management, Meaningful Improvement +9

Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus

M. Tarazi, Rebecca G. Gaffney, Carolyn J. Kushner et al. · Arthritis Care & Research · 2019 · 24 citations

Adverse Events With the Use of rhBMP-2 in Thoracolumbar and Lumbar Spine Fusions

Daniel Lubelski, Kalil G. Abdullah, Michael P. Steinmetz et al. · Journal of Spinal Disorders & Techniques · 2013 · 18 citations

Cutaneous lupus concerns from the patient perspective: a qualitative study

Daisy Yan, Danielle Zamalin, Srita Chakka et al. · Lupus Science & Medicine · 2021 · 15 citations · Full text